북미의 항체 탐색 시장 예측(-2030년) - 지역별 분석 : 항체 유형별, 성질별, 서비스별, 최종사용자별

The North America antibody discovery market was valued at US$ 12,98,237.57 million in 2022 and is expected to reach US$ 22,01,692.41 million by 2030; it is estimated to register a CAGR of 6.8% from 2022 to 2030.

Increasing Investments in Research & Development Fuel North America Antibody Discovery Market

Antibodies, including monoclonal and polyclonal, find applications in academic, research, and pharmaceutical institutes and organizations, wherein they are used in several R&D activities related to drug and biomarker development, and other therapeutic and clinical diagnostics product development. Small and medium-sized companies focus on raising their R&D investments every year. In April 2020, the US federal government assigned US$ 3.5 billion to the Biomedical Advanced Research and Development Authority (BARDA) under its Coronavirus Aid, Relief, and Economic Security (CARES) Act to provide financial support for the manufacturing, production, and procurement of vaccines, diagnostics, therapeutics, and small molecule active pharmaceutical ingredients (APIs), among others. Further, Bio-Rad, a pharmaceutical company, provides 10,000 antibodies, along with antigens, reagents, and buffers, to develop in vitro diagnostic tests. Therefore, the increasing investments by pharmaceutical companies in research and development activities related to antibody discovery to develop better treatment options for various diseases propels the antibody discovery market growth.

North America Antibody Discovery Market Overview

The North America antibody discovery market is segmented into the US, Canada, and Mexico. Market growth in the region is determined by an increase in the prevalence of cancer, the strong presence of the antibody research industry, and technological advancements in the R&D sector. According to the American Cancer Society, ~1.8 million new cancer cases were diagnosed and ~606,520 deaths related to cancer were recorded in the US in 2020. This bolsters the need for therapeutic antibodies, thereby fueling the antibody discovery market growth. An upsurge in funding further enables the development of new technologies, pooling of resources and expertise across countries and organizations, and conducting research work into existing antibody treatments. This has led to a better understanding of the immune system, and the development of effective and targeted antibodies. Additionally, the increased funding allows scientists to conduct large-scale clinical trials that are mandatory to evaluate the effectiveness of a particular antibody.

North America Antibody Discovery Market Revenue and Forecast to 2030 (US$ Billion)

North America Antibody Discovery Market Segmentation

The North America antibody discovery market is categorized into antibody type, nature, services, end user, and country.

Based on antibody type, the North America antibody discovery market is segmented into monoclonal antibodies, polyclonal antibodies, and others. The monoclonal antibodies segment held the largest North America antibody discovery market share in 2022.

In terms of nature, the North America antibody discovery market is segmented into human and humanized, chimeric, and murine. The human and humanized segment held the largest North America antibody discovery market share in 2022.

By services, the North America antibody discovery market is divided into phage display, hybridoma, transgenic animal, single cell, and yeast display. The phage display segment held the largest North America antibody discovery market share in 2022.

Based on end user, the North America antibody discovery market is categorized into pharmaceutical and biotechnology companies, research laboratories, and others. The pharmaceutical and biotechnology companies segment held the largest North America antibody discovery market share in 2022.

Based on country, the North America antibody discovery market is categorized into the US, Canada, and Mexico. The US dominated the North America antibody discovery market share in 2022.

Charles River Laboratories International Inc, Creative Biolabs Inc, Evotec SE, Bruker Cellular Analysis Inc, BioDuro LLC, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp, NanoCellect Biomedical Inc, and Biocytogen Pharmaceuticals Beijing Co Ltd. are some of the leading companies operating in the North America antibody discovery market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. North America Antibody Discovery Market - Key Market Dynamics

• 4.1 Market Drivers
  • 4.1.1 Increasing Investments in Research & Development
  • 4.1.2 Rising Incidence of Cancer
• 4.2 Market Restraints
  • 4.2.1 High Cost of Production
• 4.3 Market Opportunities
  • 4.3.1 Proliferation of Biotechnology Industry in Developing Regions
• 4.4 Future Trends
  • 4.4.1 Developments for Custom Antibodies
• 4.5 Impact of Drivers and Restraints:

5. Antibody Discovery Market - North America Market Analysis

• 5.1 North America Antibody Discovery Market Revenue (US$ Million), 2020-2030

6. North America Antibody Discovery Market Analysis - by Antibody Type

• 6.1 Overview
• 6.2 Monoclonal Antibodies
  • 6.2.1 Overview
  • 6.2.2 Monoclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
• 6.3 Polyclonal Antibodies
  • 6.3.1 Overview
  • 6.3.2 Polyclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
• 6.4 Others
  • 6.4.1 Overview
  • 6.4.2 Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Antibody Discovery Market Analysis - by Nature

• 7.1 Overview
• 7.2 Human and Humanized
  • 7.2.1 Overview
  • 7.2.2 Human and Humanized: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
• 7.3 Chimeric
  • 7.3.1 Overview
  • 7.3.2 Chimeric: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
• 7.4 Murine
  • 7.4.1 Overview
  • 7.4.2 Murine: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Antibody Discovery Market Analysis - by Services

• 8.1 Overview
• 8.2 Phage Display
  • 8.2.1 Overview
  • 8.2.2 Phage Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
• 8.3 Hybridoma
  • 8.3.1 Overview
  • 8.3.2 Hybridoma: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
• 8.4 Transgenic Animal
  • 8.4.1 Overview
  • 8.4.2 Transgenic Animal: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
• 8.5 Yeast Display
  • 8.5.1 Overview
  • 8.5.2 Yeast Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
• 8.6 Single Cell
  • 8.6.1 Overview
  • 8.6.2 Single Cell: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Antibody Discovery Market Analysis - by End User

• 9.1 Overview
• 9.2 Pharmaceutical and Biotechnology Companies
  • 9.2.1 Overview
  • 9.2.2 Pharmaceutical and Biotechnology Companies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
• 9.3 Research Laboratories
  • 9.3.1 Overview
  • 9.3.2 Research Laboratories: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
• 9.4 Others
  • 9.4.1 Overview
  • 9.4.2 Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Antibody Discovery Market - Country Analysis

• 10.1 North America Market Overview
  • 10.1.1 North America: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
    • 10.1.1.1 US
      • 10.1.1.1.1 Overview
      • 10.1.1.1.2 US: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.1.3 United States: Antibody Discovery Market Breakdown, by Antibody Type
      • 10.1.1.1.4 United States: Antibody Discovery Market Breakdown, by Nature
      • 10.1.1.1.5 United States: Antibody Discovery Market Breakdown, by Services
      • 10.1.1.1.6 United States: Antibody Discovery Market Breakdown, by End User
    • 10.1.1.2 Canada
      • 10.1.1.2.1 Overview
      • 10.1.1.2.2 Canada: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.2.3 Canada: Antibody Discovery Market Breakdown, by Antibody Type
      • 10.1.1.2.4 Canada: Antibody Discovery Market Breakdown, by Nature
      • 10.1.1.2.5 Canada: Antibody Discovery Market Breakdown, by Services
      • 10.1.1.2.6 Canada: Antibody Discovery Market Breakdown, by End User
    • 10.1.1.3 Mexico
      • 10.1.1.3.1 Overview
      • 10.1.1.3.2 Mexico: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.3.3 Mexico: Antibody Discovery Market Breakdown, by Antibody Type
      • 10.1.1.3.4 Mexico: Antibody Discovery Market Breakdown, by Nature
      • 10.1.1.3.5 Mexico: Antibody Discovery Market Breakdown, by Services
      • 10.1.1.3.6 Mexico: Antibody Discovery Market Breakdown, by End User

11. Antibody Discovery Market-Industry Landscape

• 11.1 Overview
• 11.2 Growth Strategies in the Antibody Discovery Market
• 11.3 Inorganic Growth Strategies
  • 11.3.1 Overview
• 11.4 Organic Growth Strategies
  • 11.4.1 Overview

12. Company Profiles

• 12.1 Charles River Laboratories International Inc
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
• 12.2 Creative Biolabs Inc
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
• 12.3 Evotec SE
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
• 12.4 Bruker Cellular Analysis Inc
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
• 12.5 BioDuro LLC
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
• 12.6 Sartorius AG
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
• 12.7 Aragen Life Sciences Ltd
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
• 12.8 Twist Bioscience Corp
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
• 12.9 NanoCellect Biomedical Inc
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments
• 12.10 Biocytogen Pharmaceuticals Beijing Co Ltd
  • 12.10.1 Key Facts
  • 12.10.2 Business Description
  • 12.10.3 Products and Services
  • 12.10.4 Financial Overview
  • 12.10.5 SWOT Analysis
  • 12.10.6 Key Developments

13. Appendix

• 13.1 About The Insight Partners
• 13.2 Glossary of Terms